Global Nuclear Medicine/Radiopharmaceuticals Market Insights, Forecast to 2026
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nuclear Medicine Radiopharmaceuticals 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Nuclear Medicine Radiopharmaceuticals 3900 industry.
Based on our recent survey, we have several different scenarios about the Nuclear Medicine Radiopharmaceuticals 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5435.6 million in 2019. The market size of Nuclear Medicine Radiopharmaceuticals 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nuclear Medicine/Radiopharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nuclear Medicine/Radiopharmaceuticals market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Nuclear Medicine/Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Nuclear Medicine/Radiopharmaceuticals market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Nuclear Medicine/Radiopharmaceuticals market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Nuclear Medicine/Radiopharmaceuticals market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nuclear Medicine/Radiopharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nuclear Medicine/Radiopharmaceuticals market.
The following manufacturers are covered in this report:
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nuclear Medicine Radiopharmaceuticals 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Nuclear Medicine Radiopharmaceuticals 3900 industry.
Based on our recent survey, we have several different scenarios about the Nuclear Medicine Radiopharmaceuticals 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5435.6 million in 2019. The market size of Nuclear Medicine Radiopharmaceuticals 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nuclear Medicine/Radiopharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nuclear Medicine/Radiopharmaceuticals market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Nuclear Medicine/Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Nuclear Medicine/Radiopharmaceuticals market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Nuclear Medicine/Radiopharmaceuticals market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Nuclear Medicine/Radiopharmaceuticals market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nuclear Medicine/Radiopharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nuclear Medicine/Radiopharmaceuticals market.
The following manufacturers are covered in this report:
- China Isotope & Radiation
- Dongcheng
- Jaco
- Ciaeriar
- Advanced Molecular-imaging Solution
- Shanghai Atom Kexing
- ...
- Diagnostic
- Therapeutic
- Oncology
- Thyroid
- Cardiology
1 STUDY COVERAGE
1.1 Nuclear Medicine/Radiopharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key Nuclear Medicine/Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 Diagnostic
1.4.3 Therapeutic
1.5 Market by Application
1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Thyroid
1.5.4 Cardiology
1.6 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine/Radiopharmaceuticals Industry Impact
1.6.1 How the Covid-19 is Affecting the Nuclear Medicine/Radiopharmaceuticals Industry
1.6.1.1 Nuclear Medicine/Radiopharmaceuticals Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nuclear Medicine/Radiopharmaceuticals Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nuclear Medicine/Radiopharmaceuticals Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue 2015-2026
2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales 2015-2026
2.2 Nuclear Medicine/Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers
3.1.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nuclear Medicine/Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceuticals Revenue in 2019
3.2.5 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nuclear Medicine/Radiopharmaceuticals Price by Manufacturers
3.4 Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020)
4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020)
4.1.3 Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020)
5.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2015-2020)
5.1.3 Nuclear Medicine/Radiopharmaceuticals Price by Application (2015-2020)
5.2 Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Nuclear Medicine/Radiopharmaceuticals by Country
6.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Country
6.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
6.3 North America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
7 EUROPE
7.1 Europe Nuclear Medicine/Radiopharmaceuticals by Country
7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country
7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
7.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Region
8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region
8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Nuclear Medicine/Radiopharmaceuticals by Country
9.1.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country
9.1.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
9.3 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Country
10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country
10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 China Isotope & Radiation
11.1.1 China Isotope & Radiation Corporation Information
11.1.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.1.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products Offered
11.1.5 China Isotope & Radiation Recent Development
11.2 Dongcheng
11.2.1 Dongcheng Corporation Information
11.2.2 Dongcheng Description, Business Overview and Total Revenue
11.2.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Products Offered
11.2.5 Dongcheng Recent Development
11.3 Jaco
11.3.1 Jaco Corporation Information
11.3.2 Jaco Description, Business Overview and Total Revenue
11.3.3 Jaco Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Products Offered
11.3.5 Jaco Recent Development
11.4 Ciaeriar
11.4.1 Ciaeriar Corporation Information
11.4.2 Ciaeriar Description, Business Overview and Total Revenue
11.4.3 Ciaeriar Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Products Offered
11.4.5 Ciaeriar Recent Development
11.5 Advanced Molecular-imaging Solution
11.5.1 Advanced Molecular-imaging Solution Corporation Information
11.5.2 Advanced Molecular-imaging Solution Description, Business Overview and Total Revenue
11.5.3 Advanced Molecular-imaging Solution Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Products Offered
11.5.5 Advanced Molecular-imaging Solution Recent Development
11.6 Shanghai Atom Kexing
11.6.1 Shanghai Atom Kexing Corporation Information
11.6.2 Shanghai Atom Kexing Description, Business Overview and Total Revenue
11.6.3 Shanghai Atom Kexing Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Products Offered
11.6.5 Shanghai Atom Kexing Recent Development
11.1 China Isotope & Radiation
11.1.1 China Isotope & Radiation Corporation Information
11.1.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.1.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products Offered
11.1.5 China Isotope & Radiation Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Nuclear Medicine/Radiopharmaceuticals Market Estimates and Projections by Region
12.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nuclear Medicine/Radiopharmaceuticals Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Nuclear Medicine/Radiopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Nuclear Medicine/Radiopharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key Nuclear Medicine/Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 Diagnostic
1.4.3 Therapeutic
1.5 Market by Application
1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Thyroid
1.5.4 Cardiology
1.6 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine/Radiopharmaceuticals Industry Impact
1.6.1 How the Covid-19 is Affecting the Nuclear Medicine/Radiopharmaceuticals Industry
1.6.1.1 Nuclear Medicine/Radiopharmaceuticals Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nuclear Medicine/Radiopharmaceuticals Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nuclear Medicine/Radiopharmaceuticals Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue 2015-2026
2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales 2015-2026
2.2 Nuclear Medicine/Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers
3.1.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nuclear Medicine/Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceuticals Revenue in 2019
3.2.5 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nuclear Medicine/Radiopharmaceuticals Price by Manufacturers
3.4 Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020)
4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020)
4.1.3 Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020)
5.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2015-2020)
5.1.3 Nuclear Medicine/Radiopharmaceuticals Price by Application (2015-2020)
5.2 Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Nuclear Medicine/Radiopharmaceuticals by Country
6.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Country
6.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
6.3 North America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
7 EUROPE
7.1 Europe Nuclear Medicine/Radiopharmaceuticals by Country
7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country
7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
7.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Region
8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region
8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Nuclear Medicine/Radiopharmaceuticals by Country
9.1.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country
9.1.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
9.3 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Country
10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country
10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 China Isotope & Radiation
11.1.1 China Isotope & Radiation Corporation Information
11.1.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.1.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products Offered
11.1.5 China Isotope & Radiation Recent Development
11.2 Dongcheng
11.2.1 Dongcheng Corporation Information
11.2.2 Dongcheng Description, Business Overview and Total Revenue
11.2.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Products Offered
11.2.5 Dongcheng Recent Development
11.3 Jaco
11.3.1 Jaco Corporation Information
11.3.2 Jaco Description, Business Overview and Total Revenue
11.3.3 Jaco Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Products Offered
11.3.5 Jaco Recent Development
11.4 Ciaeriar
11.4.1 Ciaeriar Corporation Information
11.4.2 Ciaeriar Description, Business Overview and Total Revenue
11.4.3 Ciaeriar Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Products Offered
11.4.5 Ciaeriar Recent Development
11.5 Advanced Molecular-imaging Solution
11.5.1 Advanced Molecular-imaging Solution Corporation Information
11.5.2 Advanced Molecular-imaging Solution Description, Business Overview and Total Revenue
11.5.3 Advanced Molecular-imaging Solution Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Products Offered
11.5.5 Advanced Molecular-imaging Solution Recent Development
11.6 Shanghai Atom Kexing
11.6.1 Shanghai Atom Kexing Corporation Information
11.6.2 Shanghai Atom Kexing Description, Business Overview and Total Revenue
11.6.3 Shanghai Atom Kexing Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Products Offered
11.6.5 Shanghai Atom Kexing Recent Development
11.1 China Isotope & Radiation
11.1.1 China Isotope & Radiation Corporation Information
11.1.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.1.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products Offered
11.1.5 China Isotope & Radiation Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Nuclear Medicine/Radiopharmaceuticals Market Estimates and Projections by Region
12.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nuclear Medicine/Radiopharmaceuticals Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Nuclear Medicine/Radiopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Nuclear Medicine/Radiopharmaceuticals Market Segments
Table 2. Ranking of Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diagnostic
Table 5. Major Manufacturers of Therapeutic
Table 6. COVID-19 Impact Global Market: (Four Nuclear Medicine/Radiopharmaceuticals Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Nuclear Medicine/Radiopharmaceuticals Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Nuclear Medicine/Radiopharmaceuticals Players to Combat Covid-19 Impact
Table 11. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions 2015-2020 (K Units)
Table 14. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 15. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 18. Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019)
Table 20. Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Price (2015-2020) (USD/Unit)
Table 23. Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
Table 25. Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 28. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 29. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 31. Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 33. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 34. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 35. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 36. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 38. North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 39. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 40. North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 41. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 42. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 43. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 44. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 46. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 47. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 48. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 49. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 58. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 59. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 62. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 63. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 64. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 65. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 74. China Isotope & Radiation Corporation Information
Table 75. China Isotope & Radiation Description and Major Businesses
Table 76. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. China Isotope & Radiation Product
Table 78. China Isotope & Radiation Recent Development
Table 79. Dongcheng Corporation Information
Table 80. Dongcheng Description and Major Businesses
Table 81. Dongcheng Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Dongcheng Product
Table 83. Dongcheng Recent Development
Table 84. Jaco Corporation Information
Table 85. Jaco Description and Major Businesses
Table 86. Jaco Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Jaco Product
Table 88. Jaco Recent Development
Table 89. Ciaeriar Corporation Information
Table 90. Ciaeriar Description and Major Businesses
Table 91. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Ciaeriar Product
Table 93. Ciaeriar Recent Development
Table 94. Advanced Molecular-imaging Solution Corporation Information
Table 95. Advanced Molecular-imaging Solution Description and Major Businesses
Table 96. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Advanced Molecular-imaging Solution Product
Table 98. Advanced Molecular-imaging Solution Recent Development
Table 99. Shanghai Atom Kexing Corporation Information
Table 100. Shanghai Atom Kexing Description and Major Businesses
Table 101. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Shanghai Atom Kexing Product
Table 103. Shanghai Atom Kexing Recent Development
Table 104. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceuticals Players
Table 122. Nuclear Medicine/Radiopharmaceuticals Customers List
Table 123. Nuclear Medicine/Radiopharmaceuticals Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 1. Nuclear Medicine/Radiopharmaceuticals Market Segments
Table 2. Ranking of Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diagnostic
Table 5. Major Manufacturers of Therapeutic
Table 6. COVID-19 Impact Global Market: (Four Nuclear Medicine/Radiopharmaceuticals Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Nuclear Medicine/Radiopharmaceuticals Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Nuclear Medicine/Radiopharmaceuticals Players to Combat Covid-19 Impact
Table 11. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions 2015-2020 (K Units)
Table 14. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 15. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 18. Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019)
Table 20. Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Price (2015-2020) (USD/Unit)
Table 23. Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
Table 25. Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 28. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 29. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 31. Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 33. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 34. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 35. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 36. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 38. North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 39. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 40. North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 41. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 42. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 43. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 44. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 46. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 47. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 48. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 49. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 58. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 59. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 62. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 63. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 64. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 65. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 74. China Isotope & Radiation Corporation Information
Table 75. China Isotope & Radiation Description and Major Businesses
Table 76. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. China Isotope & Radiation Product
Table 78. China Isotope & Radiation Recent Development
Table 79. Dongcheng Corporation Information
Table 80. Dongcheng Description and Major Businesses
Table 81. Dongcheng Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Dongcheng Product
Table 83. Dongcheng Recent Development
Table 84. Jaco Corporation Information
Table 85. Jaco Description and Major Businesses
Table 86. Jaco Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Jaco Product
Table 88. Jaco Recent Development
Table 89. Ciaeriar Corporation Information
Table 90. Ciaeriar Description and Major Businesses
Table 91. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Ciaeriar Product
Table 93. Ciaeriar Recent Development
Table 94. Advanced Molecular-imaging Solution Corporation Information
Table 95. Advanced Molecular-imaging Solution Description and Major Businesses
Table 96. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Advanced Molecular-imaging Solution Product
Table 98. Advanced Molecular-imaging Solution Recent Development
Table 99. Shanghai Atom Kexing Corporation Information
Table 100. Shanghai Atom Kexing Description and Major Businesses
Table 101. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Shanghai Atom Kexing Product
Table 103. Shanghai Atom Kexing Recent Development
Table 104. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceuticals Players
Table 122. Nuclear Medicine/Radiopharmaceuticals Customers List
Table 123. Nuclear Medicine/Radiopharmaceuticals Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Nuclear Medicine/Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Diagnostic Product Picture
Figure 4. Therapeutic Product Picture
Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology
Figure 7. Thyroid
Figure 8. Cardiology
Figure 9. Nuclear Medicine/Radiopharmaceuticals Report Years Considered
Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Sales 2015-2026 (K Units)
Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 14. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 15. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 16. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 17. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceuticals Revenue in 2019
Figure 19. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 21. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 22. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 23. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type in 2019
Figure 24. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Price Range (2015-2020)
Figure 25. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 26. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 27. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 28. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application in 2019
Figure 29. North America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 32. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 33. U.S. Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 38. North America Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 39. Europe Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 42. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 43. Germany Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 54. Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 55. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 58. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 59. China Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 82. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 83. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 86. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 87. Mexico Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 94. Latin America Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 95. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 99. Turkey Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 104. UAE Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 106. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 107. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Jaco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Ciaeriar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Advanced Molecular-imaging Solution Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Shanghai Atom Kexing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Figure 1. Nuclear Medicine/Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Diagnostic Product Picture
Figure 4. Therapeutic Product Picture
Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology
Figure 7. Thyroid
Figure 8. Cardiology
Figure 9. Nuclear Medicine/Radiopharmaceuticals Report Years Considered
Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Sales 2015-2026 (K Units)
Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 14. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 15. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 16. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 17. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceuticals Revenue in 2019
Figure 19. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 21. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 22. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 23. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type in 2019
Figure 24. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Price Range (2015-2020)
Figure 25. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 26. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 27. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 28. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application in 2019
Figure 29. North America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 32. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 33. U.S. Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 38. North America Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 39. Europe Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 42. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 43. Germany Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 54. Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 55. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 58. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 59. China Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 82. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 83. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 86. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 87. Mexico Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 94. Latin America Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 95. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 99. Turkey Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 104. UAE Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2019
Figure 106. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2019
Figure 107. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Jaco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Ciaeriar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Advanced Molecular-imaging Solution Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Shanghai Atom Kexing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
